The autophagy receptor SQSTM1/p62 mediates anti-inflammatory actions of the selective NR3C1/glucocorticoid receptor modulator compound A (CpdA) in macrophages

Glucocorticoids are widely used to treat inflammatory disorders; however, prolonged use of glucocorticoids results in side effects including osteoporosis, diabetes and obesity. Compound A (CpdA), identified as a selective NR3C1/glucocorticoid receptor (nuclear receptor subfamily 3, group C, member 1...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Autophagy
Main Authors: Mylka, Viacheslav, Deckers, Julie, Ratman, Dariusz, De Cauwer, Lode, Thommis, Jonathan, De Rycke, Riet, Impens, Francis, Libert, Claude, Tavernier, Jan, Vanden Berghe, Wim, Gevaert, Kris, De Bosscher, Karolien
Formato: Artigo
Idioma:Inglês
Publicado: Taylor & Francis 2018
Assuntos:
Research Paper - Basic Science
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6984772/
https://ncbi.nlm.nih.gov/pubmed/30215534
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15548627.2018.1495681
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares